Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

  1. Powles, T.
  2. Assaf, Z.J.
  3. Degaonkar, V.
  4. Grivas, P.
  5. Hussain, M.
  6. Oudard, S.
  7. Gschwend, J.E.
  8. Albers, P.
  9. Castellano, D.
  10. Nishiyama, H.
  11. Daneshmand, S.
  12. Sharma, S.
  13. Sethi, H.
  14. Aleshin, A.
  15. Shi, Y.
  16. Davarpanah, N.
  17. Carter, C.
  18. Bellmunt, J.
  19. Mariathasan, S.
Zeitschrift:
European Urology

ISSN: 1873-7560 0302-2838

Datum der Publikation: 2023

Art: Artikel

DOI: 10.1016/J.EURURO.2023.06.007 GOOGLE SCHOLAR